ERBB2 and cancer: To verify whether R-213 exhibits the expected dual tropism for GCN4R and HER2, we assayed its ability to infect the Vero-GCN4R cells, its wt-Vero counterpart, the HER2-positive SK-OV-3 cancer cells, and the J-HER2 cells.